Status:

COMPLETED

Pilots of Self-Collection for HPV DNA Detection

Lead Sponsor:

National Cancer Institute (NCI)

Conditions:

HPV

Eligibility:

FEMALE

21+ years

Brief Summary

This study will evaluate a method of testing for human papillomavirus (HPV) DNA. For women who have had Pap test results that are abnormal, a new test can be done for HPV, that is, viruses that someti...

Detailed Description

Background: Cytology screening programs have efficiently reduced cervical cancer incidence and mortality in the U.S. by \> 75%. However, these programs rely on the insensitive Pap smear and, conseque...

Eligibility Criteria

Inclusion

  • INCLUSION CRITERIA:
  • Women age 21 and older
  • Non-pregnant, non-hysterectomized
  • EXCLUSION CRITERIA:
  • Pregnant women and women under the age of 21 will not be included in this study.

Exclusion

    Key Trial Info

    Start Date :

    January 9 2006

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ESTIMATED

    End Date :

    December 13 2011

    Estimated Enrollment :

    300 Patients enrolled

    Trial Details

    Trial ID

    NCT00342511

    Start Date

    January 9 2006

    End Date

    December 13 2011

    Last Update

    July 2 2017

    Active Locations (2)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (2 locations)

    1

    University of Arizona

    Tucson, Arizona, United States, 85724

    2

    Cleveland Clinical Health System

    East Cleveland, Ohio, United States